logo
15:40 Dec 05

Kilitch Drugs(I) Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
336.60
-5.15 (-1.51%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Kilitch Drugs(I) Ltd. Financials

Kilitch Drugs(I) Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
336.60
-5.15 (-1.51%)
15:40 Dec 05
Quality
image/svg+xml

57/100
High Financial Strength

Valuation
image/svg+xml

47/100
Mid Valuation

Technical

35/100
Technically Neutral

Strength

10

Weakness

8

Opportunity

0

Threats

0

13.19 %

ROE %

8.53 %

ROA %

15.78

EPS

125.81

BVPS

13.46 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
114.23 139.6 154.37 198.32 209.46
Operating Expenses +
103.86 122.03 130.22 166.85 177.81
Raw Material
65.48 74.53 79.08 105.75 113.2
Increase Decrease in Cost
-0.05 0.23 -0.12 -1.17 0.08
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
6.18 11.73 10.01 11.32 12.53
Miscellaneous Expenses
32.25 35.54 41.25 50.95 52
Operating Profit
10.37 17.57 24.15 31.47 31.65
Other Income
2.91 2.92 4.48 11.16 12.65
Depreciation
2.47 3.55 3.35 3.11 3.36
Interest
1.2 4.92 5.93 5.04 5.97
Profit before tax and exceptio..
9.61 12.01 19.35 34.47 34.97
Exceptional Items
0 0 0 0 0
PBT
9.61 12.01 19.35 34.47 34.97
Provision for Taxation
3.4 3.73 5.78 9.53 8.82
Net Profit
6.21 8.28 13.58 24.94 26.13
NET Profit after MI
7.37 10.45 14.6 26.7 27.58
EPS
4.73 6.71 9.17 16.6 17.03
Operating Profit Margin (%)
9.08 12.59 15.64 15.87 15.11
Net Profit Margin (%)
6.45 7.49 9.46 13.46 13.17

Kilitch Drugs(I) Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 63.80 69.20 69.20 69.20 69.20 69.20
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 36.20 30.80 30.80 30.80 30.80 30.80
Shareholder Shares Holding %
Research 360 logo
Download Our App On: